Scholars Central

Conference abstract

Current pharmacotherapautic options for children with attention deficit hyperactivity disorders and comorbidities: A general pediatrics perspetive

Authors: Abiodun A Oyebola

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Attention Deficit Hyperactivity Disorder is probably the most common neurodevelopmental problem encoutered in children. These kids will present with inattention or difficulty with focus and hyperactivity. As a result, the family doctor and the general pediatrician are the first line of contact for the parent seeking assistance. While monotherapy is effective in treating ADHD, there are common co-morbidites associated with ADHD such as anxiety/depression, learning disorders, tourettes disorder, substance abuse and oppostional defiant disorder. Failure to treat these disorders will lead to poor outcomes in these group of children. This oral presentation will discuss monotherapy vs. combination therapy, treatment options available for the general pediatrician/family doctor in treatment of ADHD and co-morbidities.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Pediatrics & Health Research.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPediatrics & Health Research
  • SubjectPaediatrics & Neonatology
  • BylineArticles whose byline prints “Abiodun A Oyebola”